Works matching IS 13524585 AND DT 2022 AND VI 28 AND IP 5

Results: 17

Functional and structural MRI correlates of executive functions in multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 5, p. 742, doi. 10.1177/13524585211033184

By:

Marchesi, Olga;
Bonacchi, Raffaello;
Valsasina, Paola;
Preziosa, Paolo;
Pagani, Elisabetta;
Cacciaguerra, Laura;
Meani, Alessandro;
Conti, Lorenzo;
Mistri, Damiano;
Rocca, Maria A;
Filippi, Massimo

Publication type:

Article

Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 5, p. 757, doi. 10.1177/13524585211032801

By:

Ayadi, Noah;
Oertel, Frederike C;
Asseyer, Susanna;
Rust, Rebekka;
Duchow, Ankelien;
Kuchling, Joseph;
Bellmann-Strobl, Judith;
Ruprecht, Klemens;
Klistorner, Alexander;
Brandt, Alexander U;
Paul, Friedemann;
Zimmermann, Hanna G

Publication type:

Article

Cerebrospinal fluid inflammatory profile of cognitive impairment in newly diagnosed multiple sclerosis patients.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 5, p. 768, doi. 10.1177/13524585211032510

By:

Pitteri, Marco;
Magliozzi, Roberta;
Nicholas, Richard;
Ziccardi, Stefano;
Pisani, Anna Isabella;
Pezzini, Francesco;
Marastoni, Damiano;
Calabrese, Massimiliano

Publication type:

Article

In vivo imaging of chronic active lesions in multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 5, p. 683, doi. 10.1177/1352458520958589

By:

Calvi, Alberto;
Haider, Lukas;
Prados, Ferran;
Tur, Carmen;
Chard, Declan;
Barkhof, Frederik

Publication type:

Article

Stable multiple sclerosis patients on anti-CD20 therapy should go on extended interval dosing—Commentary.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 5, p. 695, doi. 10.1177/13524585211067708

By:

Gratch, Daniel;
Zhovtis Ryerson, Lana

Publication type:

Article

Stable multiple sclerosis patients on anti-CD20 therapy should go on extended interval dosing: NO.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 5, p. 693, doi. 10.1177/13524585211064441

By:

van Kempen, Zoé LE;
Hogenboom, Laura;
Killestein, Joep

Publication type:

Article

Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing data.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 5, p. 842, doi. 10.1177/13524585211061335

By:

Coles, Alasdair J;
Jones, Joanne L;
Vermersch, Patrick;
Traboulsee, Anthony;
Bass, Ann D;
Boster, Aaron;
Chan, Andrew;
Comi, Giancarlo;
Fernández, Óscar;
Giovannoni, Gavin;
Kubala Havrdova, Eva;
LaGanke, Christopher;
Montalban, Xavier;
Oreja-Guevara, Celia;
Piehl, Fredrik;
Wiendl, Heinz;
Ziemssen, Tjalf

Publication type:

Article

Stable multiple sclerosis patients on anti-CD20 therapy should go on extended interval dosing—"Yes".

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 5, p. 691, doi. 10.1177/13524585211055593

By:

Rolfes, Leoni;
Meuth, Sven G

Publication type:

Article

Long-term safety and efficacy of dimethyl fumarate for up to 13 years in patients with relapsing-remitting multiple sclerosis: Final ENDORSE study results.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 5, p. 801, doi. 10.1177/13524585211037909

By:

Gold, Ralf;
Arnold, Douglas L;
Bar-Or, Amit;
Fox, Robert J;
Kappos, Ludwig;
Mokliatchouk, Oksana;
Jiang, Xiaotong;
Lyons, Jennifer;
Kapadia, Shivani;
Miller, Catherine

Publication type:

Article

The effect of national disease-modifying therapy subsidy policy on long-term disability outcomes in people with multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 5, p. 831, doi. 10.1177/13524585211035948

By:

Claflin, Suzi B;
Campbell, Julie A;
Mason, Deborah F;
Kalincik, Tomas;
Simpson-Yap, Steve;
Norman, Richard;
Butzkueven, Helmut;
Carroll, William M;
Palmer, Andrew J;
Blizzard, C Leigh;
van der Mei, Ingrid;
Taylor, Bruce V

Publication type:

Article

Ocrelizumab treatment for relapsing-remitting multiple sclerosis after a suboptimal response to previous disease-modifying therapy: A nonrandomized controlled trial.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 5, p. 790, doi. 10.1177/13524585211035740

By:

Weinstock-Guttman, Bianca;
Bermel, Robert;
Cutter, Gary;
Freedman, Mark S;
Leist, Thomas P;
Ma, Xiaoye;
Kile, Deidre;
Musch, Bruno;
Reder, Anthony T;
Wolinsky, Jerry S

Publication type:

Article

Pregnancy in women with multiple sclerosis in France from 2010 to 2015: Incidence, outcomes, and exposure to disease-modifying therapies.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 5, p. 778, doi. 10.1177/13524585211035376

By:

Tillaut, Hélène;
Degrémont, Adeline;
Kerbrat, Sandrine;
Roux, Jonathan;
Le Page, Emmanuelle;
Mainguy, Christelle;
Duros, Solène;
Polard, Elisabeth;
Leray, Emmanuelle

Publication type:

Article

A Phase 3, double-blind, placebo-controlled efficacy and safety study of ADS-5102 (Amantadine) extended-release capsules in people with multiple sclerosis and walking impairment.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 5, p. 817, doi. 10.1177/13524585211035333

By:

Cohen, Jeffrey A;
Cameron, Michelle H;
Goldman, Myla D;
Goodman, Andrew D;
Miller, Aaron E;
Rollins, Anne;
Llorens, Lily;
Patni, Rajiv;
Elfont, Robert;
Johnson, Reed

Publication type:

Article

White matter microstructural differences in children and genetic risk for multiple sclerosis: A population-based study.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 5, p. 730, doi. 10.1177/13524585211034826

By:

de Mol, C Louk;
Neuteboom, Rinze F;
Jansen, Philip R;
White, Tonya

Publication type:

Article

Cortical involvement and leptomeningeal inflammation in myelin oligodendrocyte glycoprotein antibody disease: A three-dimensional fluid-attenuated inversion recovery MRI study.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 5, p. 718, doi. 10.1177/13524585211034362

By:

Tzanetakos, Dimitrios;
Tzartos, John S;
Vakrakou, Aigli G;
Breza, Marianthi;
Velonakis, Georgios;
Stathopoulos, Panos;
Pantou, Eirini;
Markakis, Ioannis;
Papadimitriou, Dimitra;
Karavasilis, Efstratios;
Toulas, Panagiotis;
Evangelopoulos, Μaria-Eleptheria;
Koutsis, Georgios;
Anagnostouli, Maria;
Stefanis, Leonidas;
Kilidireas, Costantinos

Publication type:

Article

Expansion of chronic MS lesions is associated with an increase of radial diffusivity in periplaque white matter.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 5, p. 697, doi. 10.1177/13524585211033464

By:

Klistorner, Samuel;
Barnett, Michael H;
Yiannikas, Con;
Barton, Joshua;
Parratt, John;
You, Yuyi;
Graham, Stuart L;
Klistorner, Alexander

Publication type:

Article

Structural and functional hippocampal alterations in Multiple sclerosis and neuromyelitis optica spectrum disorder.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 5, p. 707, doi. 10.1177/13524585211032800

By:

Zheng, Fenglian;
Li, Yuxin;
Zhuo, Zhizheng;
Duan, Yunyun;
Cao, Guanmei;
Tian, Decai;
Zhang, Xinghu;
Li, Kuncheng;
Zhou, Fuqing;
Huang, Muhua;
Li, Haiqing;
Li, Yongmei;
Zeng, Chun;
Zhang, Ningnannan;
Sun, Jie;
Yu, Chunshui;
Han, Xuemei;
Hallar, Sven;
Barkhof, Frederik;
Liu, Yaou

Publication type:

Article